1
|
Song OR, Marion E, Comoglio Y, Babonneau J, Guerineau N, Sandoz G, Yeramian E, Brodin P, Marsollier L. [Mycolactone: the amazing analgesic mycobacterial toxin]. Med Sci (Paris) 2016; 32:156-8. [PMID: 26936171 DOI: 10.1051/medsci/20163202007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Ok-Ryul Song
- Inserm U1019, CNRS UMR8204, université de Lille, Institut Pasteur de Lille, France - Inserm Avenir, Institut Pasteur Korea, Seoul, Korea
| | - Estelle Marion
- Inserm Avenir, Institut Pasteur Korea, Seoul, Korea - Inserm Avenir ATOMycA, Inserm U892, CNRS U6299, CRCNA, université et CHU d'Angers, 4, rue Larrey, 49933 Angers Cedex 9, France
| | - Yannick Comoglio
- Inserm Avenir, Laboratories of Excellence, Ion Channel Science and Therapeutics Nice, Institut de Biologie Valrose, iBV, Inserm U1091, CNRS UMR7277, université Nice Sophia Antipolis, Nice, France
| | - Jérémie Babonneau
- Inserm Avenir ATOMycA, Inserm U892, CNRS U6299, CRCNA, université et CHU d'Angers, 4, rue Larrey, 49933 Angers Cedex 9, France
| | | | - Guillaume Sandoz
- Inserm Avenir, Laboratories of Excellence, Ion Channel Science and Therapeutics Nice, Institut de Biologie Valrose, iBV, Inserm U1091, CNRS UMR7277, université Nice Sophia Antipolis, Nice, France
| | - Edouard Yeramian
- CNRS UMR 3528, unité de microbiologie structurale, Institut Pasteur, Paris, France
| | - Priscille Brodin
- Inserm Avenir, Institut Pasteur Korea, Seoul, Korea - Inserm Avenir ATOMycA, Inserm U892, CNRS U6299, CRCNA, université et CHU d'Angers, 4, rue Larrey, 49933 Angers Cedex 9, France
| | - Laurent Marsollier
- Inserm Avenir, Institut Pasteur Korea, Seoul, Korea - Inserm Avenir ATOMycA, Inserm U892, CNRS U6299, CRCNA, université et CHU d'Angers, 4, rue Larrey, 49933 Angers Cedex 9, France
| |
Collapse
|
2
|
Marion E, Landier J, Eyangoh S, Marsollier L. [Buruli ulcer: a dynamic transversal research model performed through the international network of Pasteur Institutes]. Med Sci (Paris) 2013; 29:912-7. [PMID: 24148132 DOI: 10.1051/medsci/20132910021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Buruli ulcer is an endemic severe human skin disease caused by Mycobacterium ulcerans, which prevails in western Africa in swampy areas and primarily hits children. Its gravity comes from the extent of tissue destruction, created by the toxin mycolactone. We describe here how the Centre Pasteur of Cameroon, with the help of the ministry of Health, gathered a network of multidisciplinary partners to fight against Buruli ulcer starting in the years 2000. The Centre Pasteur develops three missions : patient care, training of health care workers and research on the insect vector. Ten years of efforts resulted in significant medical advances such as the design of an early diagnostic test using PCR, or the observation that bed net use significantly decreased the risk of Buruli ulcer, offering useful prevention ; on the research side, entomological studies on aquatic bugs, coupled with epidemiological data, point to the role of these insects in the transmission of the disease. This study examplifies how an efficient network can contribute to the prevention and treatment of debilitating infectious diseases.
Collapse
Affiliation(s)
- Estelle Marion
- Service de mycobactériologie, centre Pasteur du Cameroun - Réseau international des Instituts Pasteur, BP 1274, Yaoundé, Cameroun - Centre de diagnostic et de traitement de l'ulcère de Buruli Raoul et Madeleine Follereau, BP 191, Pobè, République du Bénin
| | | | | | | |
Collapse
|